State Of Alaska, Department Of Revenue Acadia Pharmaceuticals Inc Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 73,747 shares of ACAD stock, worth $1.74 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
73,747
Previous 68,225
8.09%
Holding current value
$1.74 Million
Previous $1.13 Million
40.34%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.01 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$359 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$285 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$202 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$165 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.83B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...